Nomura Asset Management Co. Ltd. Has $37.55 Million Position in The Clorox Company $CLX

Nomura Asset Management Co. Ltd. grew its position in The Clorox Company (NYSE:CLX) by 4.7% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 372,357 shares of the company’s stock after purchasing an additional 16,852 shares during the quarter. Nomura Asset Management Co. Ltd.’s holdings in Clorox were worth $37,545,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in the stock. MUFG Securities EMEA plc increased its position in Clorox by 114.4% during the 4th quarter. MUFG Securities EMEA plc now owns 5,020 shares of the company’s stock worth $506,000 after purchasing an additional 2,679 shares in the last quarter. Sfmg LLC increased its position in Clorox by 20.1% during the 4th quarter. Sfmg LLC now owns 2,390 shares of the company’s stock worth $241,000 after purchasing an additional 400 shares in the last quarter. BNP Paribas Financial Markets increased its position in Clorox by 51.7% during the 4th quarter. BNP Paribas Financial Markets now owns 271,245 shares of the company’s stock worth $27,350,000 after purchasing an additional 92,498 shares in the last quarter. Forsta AP Fonden increased its position in Clorox by 3.2% during the 4th quarter. Forsta AP Fonden now owns 90,400 shares of the company’s stock worth $9,115,000 after purchasing an additional 2,800 shares in the last quarter. Finally, Norges Bank acquired a new position in Clorox during the 4th quarter worth approximately $135,735,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Trading Down 1.0%

NYSE:CLX opened at $89.10 on Tuesday. The firm’s fifty day moving average is $98.11 and its 200-day moving average is $105.71. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The Clorox Company has a 52 week low of $84.70 and a 52 week high of $132.03. The firm has a market cap of $10.77 billion, a P/E ratio of 14.46, a P/E/G ratio of 0.47 and a beta of 0.59.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same period in the prior year, the firm posted $1.45 EPS. The company’s quarterly revenue was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Equities analysts expect that The Clorox Company will post 5.61 earnings per share for the current year.

Insider Activity at Clorox

In other news, Director Pierre R. Breber acquired 5,000 shares of Clorox stock in a transaction dated Tuesday, May 5th. The shares were bought at an average cost of $85.82 per share, with a total value of $429,100.00. Following the purchase, the director owned 18,000 shares in the company, valued at $1,544,760. This trade represents a 38.46% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.63% of the company’s stock.

Analysts Set New Price Targets

CLX has been the subject of a number of research analyst reports. Barclays lowered their price objective on shares of Clorox from $102.00 to $85.00 and set an “underweight” rating for the company in a research report on Friday, May 1st. Rothschild & Co Redburn set a $117.00 price objective on shares of Clorox in a research report on Friday, February 13th. Morgan Stanley lowered their price objective on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a research report on Friday, May 1st. Royal Bank Of Canada reduced their target price on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a report on Thursday, April 9th. Finally, The Goldman Sachs Group reissued a “sell” rating and set a $83.00 target price on shares of Clorox in a report on Friday, May 1st. One analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have assigned a Sell rating to the company’s stock. According to data from MarketBeat, Clorox currently has an average rating of “Reduce” and an average target price of $103.40.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.